Pharming Group (PHGUF) News Today → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free PHGUF Stock Alerts $0.91 -0.04 (-4.23%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePharming Group (OTCMKTS:PHGUF) Sets New 1-Year Low at $0.95americanbankingnews.com - April 23 at 4:42 AMPharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025finance.yahoo.com - April 19 at 1:19 PMPharming Group announces the placement of €100 million convertible bonds due 2029finance.yahoo.com - April 18 at 10:28 AMOptimistic Buy Rating on Pharming Group Backed by Promising Leniolisib Trials and Strategic Market Expansionmarkets.businessinsider.com - April 8 at 3:44 PMPharming Group N.V.: Pharming announces completion of enrollment in pediatric clinical trial of leniolisibfinanznachrichten.de - April 8 at 10:44 AMPharming Group announces the 2024 Annual General Meeting of Shareholdersfinance.yahoo.com - April 4 at 3:53 AMPharming Group to participate in April investor conferencesfinance.yahoo.com - April 3 at 2:50 AMPharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Resultsfinance.yahoo.com - March 17 at 3:29 AMPharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)finance.yahoo.com - March 16 at 7:10 AMPharming Group’s Strong Financial Performance and Growth Potential Merit Buy Ratingmarkets.businessinsider.com - March 15 at 12:44 AMPharming Group to report fourth quarter and full year 2023 financial results on March 14finance.yahoo.com - February 29 at 2:25 AMPharming Group NV (PHAR)uk.investing.com - February 20 at 8:15 AMAnalysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Pharming Group (OtherPHGUF)markets.businessinsider.com - January 12 at 12:56 AMPharming Group N.V.: Pharming Group announces updated full year 2023 guidance and Joenja U.S. launch updatefinanznachrichten.de - January 8 at 8:22 AMPharming Group Projects 2023 Total Revenues To Rise 19%markets.businessinsider.com - January 8 at 8:22 AMPharming Group announces updated full year 2023 guidance and Joenja® U.S. launch updatefinance.yahoo.com - January 8 at 8:22 AMPharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisibfinance.yahoo.com - November 21 at 1:22 AMPharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approvalfinance.yahoo.com - November 10 at 9:52 AMPharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meetingfinance.yahoo.com - November 7 at 7:47 AMPharming GAAP EPS of $0.01 beats by $0.005, revenue of $66.7M beats by $4.87Mmsn.com - October 26 at 10:07 AMPharming Group N.V.: Pharming Group to report third quarter 2023 financial results on October 26finanznachrichten.de - October 12 at 3:10 AMPharming Group to report third quarter 2023 financial results on October 26finance.yahoo.com - October 12 at 3:10 AMPharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?finance.yahoo.com - September 22 at 7:55 AMPharming Group: Pipeline Progresses With APDS Phase 3 Initiationmsn.com - September 9 at 4:17 PMH.C. Wainwright Keeps Their Buy Rating on Pharming Group (PHAR)markets.businessinsider.com - August 9 at 1:50 PMPharming Group NV American Depositary Shares Repr 10 Shs Reg Smarkets.businessinsider.com - August 9 at 7:49 AMPharming Group N.V. reports Q2 resultsmsn.com - August 4 at 6:27 PMRBC Capital Sticks to Their Buy Rating for Pharming Group (PHGUF)markets.businessinsider.com - May 15 at 10:46 PMPharming Group N.V. GAAP EPS of $0.02, revenue of $42.5M misses by $6Mmsn.com - May 12 at 12:39 AMPharming Group shares are trading lower after the company reported a year-over-year decrease in Q1 EPS and revenue.benzinga.com - May 11 at 7:38 PMPharming Group NV American Depositary Shares Repr 10 earnings: here's what Wall Street expectsmarkets.businessinsider.com - May 11 at 4:25 AMPharming Group reports financial results for the first quarter of 2023finance.yahoo.com - May 11 at 4:25 AMPharming Group's (AMS:PHARM) investors will be pleased with their decent 51% return over the last yearfinance.yahoo.com - May 8 at 8:30 AMPharming Group N.V.: Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023finanznachrichten.de - April 26 at 9:56 AMPharming to attend the H.C. Wainwright BioConnect Investor Conference 2023finance.yahoo.com - April 26 at 9:56 AMPharming Group: Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023finanznachrichten.de - April 19 at 2:12 AMPharming Group N.V.: Notice of First Quarter 2023 Resultsfinanznachrichten.de - April 19 at 2:12 AMNotice of First Quarter 2023 Resultsfinance.yahoo.com - April 19 at 2:12 AMPharming to attend the Van Lanschot Kempen Life Sciences Conference 2023finance.yahoo.com - April 19 at 2:12 AMPharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.finance.yahoo.com - April 11 at 1:45 AMPharming Group announces the filing of its 2022 Annual Report and Form 20-Ffinance.yahoo.com - April 5 at 1:12 AMPharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Daysfinance.yahoo.com - March 30 at 1:51 PMFDA Approves Pharming's Immune Disorder Drug, As First APDS Therapyfinance.yahoo.com - March 27 at 1:16 PMPharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcementfinance.yahoo.com - March 13 at 4:24 AMPharming Group N.V.: Notice of Full Year 2022 financial resultsfinanznachrichten.de - February 28 at 4:08 AMNotice of Full Year 2022 financial resultsfinance.yahoo.com - February 28 at 4:08 AMPharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisibfinanznachrichten.de - February 21 at 9:23 AMPharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 49% Above Its Share Pricefinance.yahoo.com - January 9 at 7:30 AMPharming Group N.V.'s (AMS:PHARM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?finance.yahoo.com - December 19 at 6:43 AMPharming Highlights Interim Data From Rare Immune Deficiency Studyfinance.yahoo.com - December 15 at 12:19 PM Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. Email Address War Over Taiwan? Protect Your Wealth NOW (Ad)With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> PHGUF Media Mentions By Week PHGUF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGUF News Sentiment▼0.720.33▲Average Medical News Sentiment PHGUF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGUF Articles This Week▼20▲PHGUF Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LYEL News WVE News SIGA News ZYME News PRAX News AVTE News SVRA News ORIC News PHAR News GHRS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PHGUF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
